Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction

Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction

Aims: Marijuana is a widely used illicit drug and its consumption during pregnancy has been associated with adverse reproductive outcomes. The purpose of this study was to determine the effects of chronic intake of Δ9-tetrahydrocannabinol (THC), the major component of marijuana, on trophoblast funct...

Full description

Bibliographic Details
Main Authors:	Xinwen Chang, Yiding Bian, Qizhi He, Julei Yao, Jingping Zhu, Jinting Wu, Kai Wang, Tao Duan
Format:	Article
Language:	English
Published:	Cell Physiol Biochem Press GmbH & Co KG 2017-06-01
Series:	Cellular Physiology and Biochemistry
Subjects:	Marijuana/Cannabis Δ9-tetrahydrocannabinol/THC Perinatal outcomes Trophoblast dysfunction Signal Transducer and Activator of Transcription 3/STAT3
Online Access:	http://www.karger.com/Article/FullText/477603

Similar Items

Acute human exposure assessment to tetrahydrocannabinol (Δ9‐THC)
by: European Food Safety Authority (EFSA), et al.
Published: (2020-01-01)

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
by: Joshua D. Brown
Published: (2020-03-01)

Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes
by: Amos Abioye, et al.
Published: (2020-01-01)

Marijuana use in U.S. teen drivers: a comparison of a road-side survey of reported use and fluid tests for tetrahydrocannabinol (THC)
by: Joyce C. Pressley, et al.
Published: (2019-05-01)

Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry
by: Joshua D. Brown, et al.
Published: (2020-04-01)

Identification of Δ9-Tetrahydrocannabinol (Δ9-THC) in Cannabis seeds by Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry (ESI(-)FT-ICR MS)
by: Nayara A. dos Santos, et al.
Published: (2018-06-01)

Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
by: Clara Andradas, et al.
Published: (2021-01-01)

Detection of Δ9-tetrahydrocannabinol (THC) in hair using GC–MS
by: Himanshu Khajuria, et al.
Published: (2014-03-01)

Scientific Opinion on the risks for human health related to the presence of tetrahydrocannabinol (THC) in milk and other food of animal origin
by: EFSA Panel on Contaminants in the Food Chain (CONTAM)
Published: (2015-06-01)

The Impact of THC and CBD in Schizophrenia: A Systematic Review
by: Saeed Ahmed, et al.
Published: (2021-07-01)

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
by: Lourdes Poyatos, et al.
Published: (2020-06-01)

Chlorpyrifos and Δ9 Tetrahydrocannabinol exposure and effects on parameters associated with the endocannabinoid system and risk factors for obesity
by: Marilyn H. Silva
Published: (2021-01-01)

Microwave-Assisted Extraction of Cannabinoids in Hemp Nut Using Response Surface Methodology: Optimization and Comparative Study
by: Chih-Wei Chang, et al.
Published: (2017-11-01)

Do Cannabis Users Reduce Their THC Dosages When Using More Potent Cannabis Products? A Review
by: Janni Leung, et al.
Published: (2021-02-01)

The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology
by: Clara Andradas, et al.
Published: (2021-01-01)

Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?
by: Nancy De Briyne, et al.
Published: (2021-03-01)

Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)
by: Thomas Meyer, et al.
Published: (2019-09-01)

Application of modeling-based approaches to study the pharmacokinetics and pharmacodynamics of Delta-9-tetrahydrocannabinol (THC) and its active metabolite
by: Awasthi, Rakesh
Published: (2017)

A Review of Cases of Marijuana and Violence
by: Norman S. Miller, et al.
Published: (2020-02-01)

A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC
by: Seok Hee Kim, et al.
Published: (2019-12-01)

Cannabinoids from Cannabis sp.: mechanism of their activity and potential health benefits in human body
by: Grzegorz Dąbrowski, et al.
Published: (2017-08-01)

Mitragynine (Kratom)-Induced Cognitive Impairments in Mice Resemble Δ9-THC and Morphine Effects: Reversal by Cannabinoid CB1 Receptor Antagonism
by: Ismail Nurul Iman, et al.
Published: (2021-09-01)

Administration of Δ9‐Tetrahydrocannabinol (THC) Post‐Staphylococcal Enterotoxin B Exposure Protects Mice From Acute Respiratory Distress Syndrome and Toxicity
by: Amira Mohammed, et al.
Published: (2020-06-01)

Genetic Modulation of Initial Sensitivity to Δ9-Tetrahydrocannabinol (THC) Among the BXD Family of Mice
by: Cory Parks, et al.
Published: (2021-07-01)

Efficacy of Δ9 -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice
by: Prakash Nidadavolu, et al.
Published: (2021-08-01)

Chronic exposure to delta-9-tetrahydrocannabinol impacts testicular volume and male reproductive health in rhesus macaques
by: Bash, J.C, et al.
Published: (2022)

Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
by: Francesco Bartoli, et al.
Published: (2021-03-01)

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
by: Paul T. Kocis, et al.
Published: (2020-07-01)

Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey
by: Jamie Corroon, et al.
Published: (2019-12-01)

Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial
by: Erin L. Martin, et al.
Published: (2021-09-01)

Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
by: Patricia Golombek, et al.
Published: (2020-06-01)

EVALI Vaping Liquids Part 1: GC-MS Cannabinoids Profiles and Identification of Unnatural THC Isomers
by: Laura A. Ciolino, et al.
Published: (2021-09-01)

Epigenetic Mediation of <i>AKT1</i> rs1130233’s Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing
by: Grace Blest-Hopley, et al.
Published: (2021-09-01)

Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity
by: Swapnali Chetia, et al.
Published: (2020-08-01)

A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ9-Tetrahydrocannabinol
by: Salahaden R. Sultan, et al.
Published: (2018-01-01)

Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
by: Jerome Sarris, et al.
Published: (2020-01-01)

Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
by: Mina G. Nashed, et al.
Published: (2021-01-01)

Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
by: Eric P. Baron, et al.
Published: (2018-05-01)

Potential impacts of soil microbiota manipulation on secondary metabolites production in cannabis
by: Bulbul Ahmed, et al.
Published: (2021-07-01)

A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeutics
by: Kevin P. Hill, et al.
Published: (2021-07-01)

Cannot write session to /tmp/vufind_sessions/sess_2eohn2bvfva98q1v8ngu8qekhk